Menu

Blog

Archive for the ‘genetics’ category: Page 437

Jul 26, 2017

New Study Suggests Previous Concerns about CRISPR Safety are Questionable

Posted by in categories: bioengineering, biotech/medical, food, genetics, life extension

Gene editing aims to make precise changes to the target DNA whilst avoiding altering other parts of the DNA. The objective of this is to remove undesirable genetic traits and introduce desirable changes in both plants and animals. For example, it could be used to make crops more drought resistant, prevent or cure inherited genetic disorders or even treat age-related diseases.

As some of you may recall, back in May a study was published which claimed that the groundbreaking gene editing technique CRISPR caused thousands of off target and potentially dangerous mutations[1]. The authors of the paper called for regulators to investigate the safety of the technique, a move that could potentially set back research years if not decades.

This publication has been widely blasted by the research community due to serious questions about the study design being raised. One of the problems with this original paper was that it involved only three mice, this is an extremely poor number to make the kind of conclusions the paper did. There have been calls for the paper to be withdrawn and critical responses to the study.

Read more

Jul 24, 2017

New Cancer Vaccine Shows Promising Results in Human Clinical Trial

Posted by in categories: biotech/medical, genetics, life extension

Customized cancer vaccines that match the unique genetic makeup of individual tumors have just passed phase 1 trials.


Cancer is predominantly a disease of aging caused by genomic instability. Finding effective ways to prevent and treat cancer is therefore of great interest to those working in the field of aging research as well as those working in oncology.

Therapies that target combinations of neoantigens, distinctive markers on the surface of cancer cells that the immune system learns to identify, is one potential approach to treating cancer. These neoantigen combinations vary between one patient and another and this is the focus of a new study which we will talk about today[1].

Continue reading “New Cancer Vaccine Shows Promising Results in Human Clinical Trial” »

Jul 22, 2017

Zoltan Istvan: the poster boy for immortality

Posted by in categories: cyborgs, economics, genetics, life extension, open access, robotics/AI, transhumanism

I’m really excited to announce a 5-page feature spread on my #transhumanism work and Libertarian Governor campaign in today’s Times of London Magazine, one of England’s oldest and largest papers. There’s a paywall for digital but I think you can get two articles free without registering. If you have access to the print, it’s in the magazine:


Zoltan Istvan is launching his campaign to become Libertarian governor of California with two signature policies. First, he’ll eliminate poverty with a universal basic income that will guarantee $5,000 (£3,800) per month for every Californian household for ever. (He’ll do this without raising taxes a dime, he promises.) The next item in his in-tray is eliminating death. He intends to divert trillions of dollars into life-extending technologies – robotic hearts, artificial exoskeletons, genetic editing, bionic limbs and so on – in the hope that each Californian man, woman and AI (artificial intelligence) will eventually be able to upload their consciousness to the Cloud and experience digital eternity.

“What we can experience as a human being is going to be dramatically different within two decades,” he…

Continue reading “Zoltan Istvan: the poster boy for immortality” »

Jul 20, 2017

Building the Safe Genes Toolkit

Posted by in categories: bioengineering, biotech/medical, genetics, health, security

DARPA created the Safe Genes program to gain a fundamental understanding of how gene editing technologies function; devise means to safely, responsibly, and predictably harness them for beneficial ends; and address potential health and security concerns related to their accidental or intentional misuse. Today, DARPA announced awards to seven teams that will pursue that mission, led by: The Broad Institute of MIT and Harvard; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology; North Carolina State University; University of California, Berkeley; and University of California, Riverside. DARPA plans to invest $65 million in Safe Genes over the next four years as these teams work to collect empirical data and develop a suite of versatile tools that can be applied independently or in combination to support bio-innovation and combat bio-threats.

Gene editing technologies have captured increasing attention from healthcare professionals, policymakers, and community leaders in recent years for their potential to selectively disable cancerous cells in the body, control populations of disease-spreading mosquitos, and defend native flora and fauna against invasive species, among other uses. The potential national security applications and implications of these technologies are equally profound, including protection of troops against infectious disease, mitigation of threats posed by irresponsible or nefarious use of biological technologies, and enhanced development of new resources derived from synthetic biology, such as novel chemicals, materials, and coatings with useful, unique properties.

Achieving such ambitious goals, however, will require more complete knowledge about how gene editors, and derivative technologies including gene drives, function at various physical and temporal scales under different environmental conditions, across multiple generations of an organism. In parallel, demonstrating the ability to precisely control gene edits, turning them on and off under certain conditions or even reversing their effects entirely, will be paramount to translation of these tools to practical applications. By establishing empirical foundations and removing lingering unknowns through laboratory-based demonstrations, the Safe Genes teams will work to substantially minimize the risks inherent in such powerful tools.

Read more

Jul 17, 2017

A New Technique Transforms Human Skin Into Brain Cells

Posted by in categories: biotech/medical, genetics, neuroscience

“Microglia play an important role in Alzheimer’s and other diseases of the central nervous system. Recent research has revealed that newly discovered Alzheimer’s-risk genes influence microglia behavior,” Jones said in an interview for a UCI press release. “Using these cells, we can understand the biology of these genes and test potential new therapies.”

A Renewable Method

Continue reading “A New Technique Transforms Human Skin Into Brain Cells” »

Jul 17, 2017

Epigenetics between the generations: Researchers prove that we inherit more than just genes

Posted by in categories: biotech/medical, food, genetics

We are more than the sum of our genes. Epigenetic mechanisms modulated by environmental cues such as diet, disease or lifestyle take a major role in regulating the DNA by switching genes on and off. It has been long debated if epigenetic modifications accumulated throughout the entire life can cross the border of generations and be inherited to children or even grand children. Now researchers from the Max Planck Institute of Immunobiology and Epigenetics in Freiburg show robust evidence that not only the inherited DNA itself but also the inherited epigenetic instructions contribute in regulating gene expression in the offspring. Moreover, the new insights by the Lab of Nicola Iovino describe for the first time biological consequences of this inherited information. The study proves that mother’s epigenetic memory is essential for the development and survival of the new generation.

Humans have than 250 different cell types. They all contain the exact same DNA bases in exactly the same order; however, liver or nerve cells look very different and have different skills. What makes the difference is a process called epigenetics. Epigenetic modifications label specific regions of the DNA to attract or keep away proteins that activate genes. Thus, these modifications create, step by step, the typical patterns of active and inactive DNA sequences for each cell type. Moreover, contrary to the fixed sequence of ‘letters’ in DNA, can also change throughout life and in responses to environment or lifestyle. For example, smoking changes the epigenetic makeup of lung cells, eventually leading to cancer. Other influences of external stimuli like stress, disease or diet are also supposed to be stored in the of cells.

It has long been thought that these epigenetic modifications never cross the border of generations. Scientists assumed that epigenetic memory accumulated throughout life is entirely cleared during the development of sperms and egg cells. Just recently a handful of studies stirred the scientific community by showing that epigenetic marks indeed can be transmitted over generations, but exactly how, and what effects these genetic modifications have in the offspring is not yet understood. “We saw indications of intergenerational inheritance of epigenetic information since the rise of the epigenetics in the early nineties. For instance, epidemiological studies revealed a striking correlation between the food supply of grandfathers and an increased risk of diabetes and cardiovascular disease in their grandchildren.

Read more

Jul 15, 2017

Biosensors could give soldiers superhuman fighting abilities

Posted by in categories: computing, genetics, military, neuroscience

According to the report, the US Air Force, Marine Corps, Navy and other special forces are looking to improve troops’ performance by looking at their bodies at a genetic level (stock)

Earlier this year the AirForce successfully tested a helmet that can monitor brain activity and tell if the pilot is feeling stressed or panicked.

Continue reading “Biosensors could give soldiers superhuman fighting abilities” »

Jul 15, 2017

Does the Fountain of Youth really exist?

Posted by in categories: genetics, life extension

Previously he said 10 years and that was 2016 where he said 2 years until phase 1 human trials.


Is it an impossible dream to find Ponce de Leon’s Fountain of Youth? No! I’ve just attended my 67th reunion at The Harvard Medical School (HMS) and, while interviewing Dr. George Church, I discovered it is no longer science fiction.

Dr. Church, Professor of Genetics at HMS, one of the world’s great scientists, predicts we are about to end the aging process. In the next five years no less! That’s why I say — damn it! I was born too soon.

Continue reading “Does the Fountain of Youth really exist?” »

Jul 14, 2017

This Is How Gene-Editing Will Change The Food You Eat

Posted by in categories: biotech/medical, food, genetics

For example, in 1994 Calgene won approval to sell the Flavr Savr tomato. To make a Flavr Savr, scientists genetically modified a garden variety tomato with aminoglycoside 3-phosphotransferase II, a compound that kept the fruit from rotting.

The tinkering sabotaged the process that makes tomatoes turn squishy. But the less-squishy tomatoes never did catch on with a skeptical public. The company was later sold to Monsanto.


It changed everything.

Continue reading “This Is How Gene-Editing Will Change The Food You Eat” »

Jul 14, 2017

Synthetic Biology and the Future of Creation

Posted by in categories: bioengineering, biotech/medical, genetics

For decades, biologists have read and edited DNA, the code of life. Revolutionary developments are giving scientists the power to write it. Instead of tinkering with existing life forms, synthetic biologists may be on the verge of writing the DNA of a living organism from scratch. In the next decade, according to some, we may even see the first synthetic human genome. Join a distinguished group of synthetic biologists, geneticists and bioengineers who are edging closer to breathing life into matter.

Watch the full program here: https://youtu.be/rU_pfCtSWF4

Continue reading “Synthetic Biology and the Future of Creation” »